- Home
- PCOR vs ARWR Comparison
PCOR vs ARWR Comparison
Compare PCOR & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PCOR | ARWR |
|---|---|---|
| Founded | 2003 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.9B | 9.6B |
| IPO Year | 2021 | 1993 |
Fundamental Metrics
Financial Performance| Metric | PCOR | ARWR |
|---|---|---|
| Price | $73.92 | $69.36 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 10 |
| Target Price | ★ $89.71 | $63.70 |
| AVG Volume (30 Days) | 1.2M | ★ 3.2M |
| Earning Date | 02-12-2026 | 02-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,275,450,000.00 | $829,448,000.00 |
| Revenue This Year | $16.35 | N/A |
| Revenue Next Year | $12.09 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 14.94 | ★ 23258.15 |
| 52 Week Low | $53.71 | $9.57 |
| 52 Week High | $88.92 | $72.36 |
Technical Indicators
Market Signals| Indicator | PCOR | ARWR |
|---|---|---|
| Relative Strength Index (RSI) | 47.73 | 69.45 |
| Support Level | $73.64 | $59.51 |
| Resistance Level | $76.13 | $72.36 |
| Average True Range (ATR) | 2.16 | 3.90 |
| MACD | -0.20 | -0.49 |
| Stochastic Oscillator | 33.33 | 75.91 |
Price Performance
Historical ComparisonAbout PCOR Procore Technologies Inc.
Procore Technologies Inc is a cloud-based construction management software company. It generates revenue through subscriptions for access to its software products. The company's products include Design Coordination, BIM, Field Productivity, Project Financials, Invoice Management, Portfolio Financials, Capital Planning, Accounting Integrations, and Analytics. The software products are hosted on its cloud-based SaaS construction management platform. Subscriptions are sold for a fixed fee and revenue is recognized ratably over the term of the subscription.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.